Literature DB >> 15812814

Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis.

Dongwei Wang1, Margaret M Ayers, Deanne V Catmull, Lisa J Hazelwood, Claude C A Bernard, Jacqueline M Orian.   

Abstract

Recent studies of axon-glia and glia-glia communication have emphasized interactivity and interdependence between central nervous system (CNS) components. Concurrently, data from imaging, biochemical, and morphological studies have changed the view of multiple sclerosis (MS) from a neuroinflammatory condition with primary demyelination to one in which cumulative axonal damage drives progression. We therefore studied axonal damage in the context of inflammation and glial responses, from the pre-clinical to onset stage of murine experimental autoimmune encephalomyelitis (EAE), an established MS model. We report three major findings: (1) the first evidence of axonal injury before significant T-cell entry into the parenchyma, (3) coincidence of the earliest manifestation of axonal damage and astrocytic responses, and (3) an association between accumulation of axonal and astrocytic changes and specific forms of MS. These data demonstrate the relationship between the initiation of axonal injury and early inflammation. Significantly, we show that, in common with a growing number of neurodegenerative conditions, the pathology of murine EAE is characterized by early active contribution from astrocytes. This marks a change in the understanding of the role of astrocytes in MS pathogenesis and has important implications for the development of neuroprotective strategies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15812814     DOI: 10.1002/glia.20199

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  43 in total

1.  Transfer of myelin-reactive th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice.

Authors:  Emily G Baxi; Joseph DeBruin; Dominique M Tosi; Inna V Grishkan; Matthew D Smith; Leslie A Kirby; Hayley J Strasburger; Amanda N Fairchild; Peter A Calabresi; Anne R Gocke
Journal:  J Neurosci       Date:  2015-06-03       Impact factor: 6.167

Review 2.  Translational research in neurology and neuroscience 2010: multiple sclerosis.

Authors:  Olaf Stüve; Bernd C Kieseier; Bernhard Hemmer; Hans-Peter Hartung; Amer Awad; Elliot M Frohman; Benjamin M Greenberg; Michael K Racke; Scott S Zamvil; J Theodore Phillips; Ralf Gold; Andrew Chan; Uwe Zettl; Ron Milo; Ellen Marder; Omar Khan; Todd N Eagar
Journal:  Arch Neurol       Date:  2010-07-12

3.  Reactivated astrocytes as a possible source of oligodendrocyte precursors for remyelination in remitting phase of experimental autoimmune encephalomyelitis rats.

Authors:  An-Chen Guo; Takho Chu; Xu-Qing Liu; Huan-Xing Su; Wu-Tian Wu
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 4.  Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis.

Authors:  Lisa K Peterson; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2006-12-28       Impact factor: 3.478

5.  Myelin phagocytosis by astrocytes after myelin damage promotes lesion pathology.

Authors:  Gerald Ponath; Sriram Ramanan; Mayyan Mubarak; William Housley; Seunghoon Lee; F Rezan Sahinkaya; Alexander Vortmeyer; Cedric S Raine; David Pitt
Journal:  Brain       Date:  2016-12-21       Impact factor: 13.501

6.  The flavonoid Baicalein attenuates cuprizone-induced demyelination via suppression of neuroinflammation.

Authors:  Miho Hashimoto; Shinji Yamamoto; Kensuke Iwasa; Kota Yamashina; Masaki Ishikawa; Kei Maruyama; Francesca Bosetti; Keisuke Yoshikawa
Journal:  Brain Res Bull       Date:  2017-09-15       Impact factor: 4.077

7.  A novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseases.

Authors:  Krishnakumar N Menon; David L Steer; Martin Short; Steven Petratos; Ian Smith; Claude C A Bernard
Journal:  Mol Cell Proteomics       Date:  2011-03-18       Impact factor: 5.911

Review 8.  The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Roberta Brambilla
Journal:  Acta Neuropathol       Date:  2019-03-07       Impact factor: 17.088

9.  Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation.

Authors:  Roberta Brambilla; Trikaldarshi Persaud; Xianchen Hu; Shaffiat Karmally; Valery I Shestopalov; Galina Dvoriantchikova; Dmitry Ivanov; Lubov Nathanson; Scott R Barnum; John R Bethea
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

10.  Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.

Authors:  Athena M Soulika; Eunyoung Lee; Erica McCauley; Laird Miers; Peter Bannerman; David Pleasure
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.